HENRY SCHEIN INC (HSIC) Stock Fundamental Analysis

NASDAQ:HSIC • US8064071025

83.35 USD
+2.78 (+3.45%)
At close: Feb 24, 2026
83.35 USD
0 (0%)
After Hours: 2/24/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to HSIC. HSIC was compared to 101 industry peers in the Health Care Providers & Services industry. HSIC has only an average score on both its financial health and profitability. HSIC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • HSIC had positive earnings in the past year.
  • In the past year HSIC had a positive cash flow from operations.
  • HSIC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years HSIC had a positive operating cash flow.
HSIC Yearly Net Income VS EBIT VS OCF VS FCFHSIC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of HSIC (3.52%) is better than 65.35% of its industry peers.
  • With a decent Return On Equity value of 11.63%, HSIC is doing good in the industry, outperforming 76.24% of the companies in the same industry.
  • The Return On Invested Capital of HSIC (6.64%) is better than 64.36% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HSIC is in line with the industry average of 8.93%.
Industry RankSector Rank
ROA 3.52%
ROE 11.63%
ROIC 6.64%
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
HSIC Yearly ROA, ROE, ROICHSIC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • HSIC has a Profit Margin of 3.02%. This is in the better half of the industry: HSIC outperforms 66.34% of its industry peers.
  • In the last couple of years the Profit Margin of HSIC has declined.
  • Looking at the Operating Margin, with a value of 5.94%, HSIC is in the better half of the industry, outperforming 65.35% of the companies in the same industry.
  • HSIC's Operating Margin has declined in the last couple of years.
  • HSIC has a Gross Margin of 31.19%. This is comparable to the rest of the industry: HSIC outperforms 59.41% of its industry peers.
  • In the last couple of years the Gross Margin of HSIC has remained more or less at the same level.
Industry RankSector Rank
OM 5.94%
PM (TTM) 3.02%
GM 31.19%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
HSIC Yearly Profit, Operating, Gross MarginsHSIC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • HSIC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for HSIC has been reduced compared to 1 year ago.
  • HSIC has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for HSIC is higher compared to a year ago.
HSIC Yearly Shares OutstandingHSIC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
HSIC Yearly Total Debt VS Total AssetsHSIC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.69 indicates that HSIC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • HSIC's Altman-Z score of 2.69 is fine compared to the rest of the industry. HSIC outperforms 60.40% of its industry peers.
  • The Debt to FCF ratio of HSIC is 8.70, which is on the high side as it means it would take HSIC, 8.70 years of fcf income to pay off all of its debts.
  • HSIC has a Debt to FCF ratio (8.70) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.91 indicates that HSIC is somewhat dependend on debt financing.
  • HSIC has a Debt to Equity ratio (0.91) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 8.7
Altman-Z 2.69
ROIC/WACC0.83
WACC8%
HSIC Yearly LT Debt VS Equity VS FCFHSIC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • HSIC has a Current Ratio of 1.40. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
  • HSIC's Current ratio of 1.40 is in line compared to the rest of the industry. HSIC outperforms 52.48% of its industry peers.
  • A Quick Ratio of 0.79 indicates that HSIC may have some problems paying its short term obligations.
  • HSIC's Quick ratio of 0.79 is on the low side compared to the rest of the industry. HSIC is outperformed by 76.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.79
HSIC Yearly Current Assets VS Current LiabilitesHSIC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 14.49% over the past year.
  • HSIC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.19% yearly.
  • The Revenue has been growing slightly by 3.51% in the past year.
  • The Revenue has been growing slightly by 4.88% on average over the past years.
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.78% on average over the next years.
  • The Revenue is expected to grow by 3.31% on average over the next years.
EPS Next Y5.82%
EPS Next 2Y6.79%
EPS Next 3Y7.97%
EPS Next 5Y7.78%
Revenue Next Year2.46%
Revenue Next 2Y2.93%
Revenue Next 3Y3.21%
Revenue Next 5Y3.31%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HSIC Yearly Revenue VS EstimatesHSIC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
HSIC Yearly EPS VS EstimatesHSIC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.29, the valuation of HSIC can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of HSIC indicates a rather cheap valuation: HSIC is cheaper than 80.20% of the companies listed in the same industry.
  • HSIC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.98, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 15.42, the valuation of HSIC can be described as correct.
  • Based on the Price/Forward Earnings ratio, HSIC is valued cheaply inside the industry as 80.20% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of HSIC to the average of the S&P500 Index (28.01), we can say HSIC is valued slightly cheaper.
Industry RankSector Rank
PE 17.29
Fwd PE 15.42
HSIC Price Earnings VS Forward Price EarningsHSIC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 72.28% of the companies in the same industry are more expensive than HSIC, based on the Enterprise Value to EBITDA ratio.
  • HSIC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 27.56
EV/EBITDA 10.74
HSIC Per share dataHSIC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • HSIC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.97
PEG (5Y)2.79
EPS Next 2Y6.79%
EPS Next 3Y7.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for HSIC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HENRY SCHEIN INC

NASDAQ:HSIC (2/24/2026, 8:00:02 PM)

After market: 83.35 0 (0%)

83.35

+2.78 (+3.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04
Earnings (Next)02-24
Inst Owners97.45%
Inst Owner Change-4.26%
Ins Owners0.79%
Ins Owner Change-0.21%
Market Cap9.81B
Revenue(TTM)12.94B
Net Income(TTM)391.00M
Analysts72.17
Price Target79.3 (-4.86%)
Short Float %5.13%
Short Ratio4.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.88%
Min EPS beat(2)-9.54%
Max EPS beat(2)5.78%
EPS beat(4)2
Avg EPS beat(4)-1.38%
Min EPS beat(4)-9.54%
Max EPS beat(4)5.78%
EPS beat(8)4
Avg EPS beat(8)-0.56%
EPS beat(12)5
Avg EPS beat(12)-0.94%
EPS beat(16)7
Avg EPS beat(16)0.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.59%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)-0.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)0
Avg Revenue beat(12)-3.01%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)0%
PT rev (3m)0.75%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)0.06%
EPS NY rev (1m)0%
EPS NY rev (3m)1.98%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.09%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 17.29
Fwd PE 15.42
P/S 0.76
P/FCF 27.56
P/OCF 18.34
P/B 2.92
P/tB N/A
EV/EBITDA 10.74
EPS(TTM)4.82
EY5.78%
EPS(NY)5.41
Fwd EY6.48%
FCF(TTM)3.02
FCFY3.63%
OCF(TTM)4.54
OCFY5.45%
SpS109.9
BVpS28.55
TBVpS-15.56
PEG (NY)2.97
PEG (5Y)2.79
Graham Number55.64
Profitability
Industry RankSector Rank
ROA 3.52%
ROE 11.63%
ROCE 9.68%
ROIC 6.64%
ROICexc 6.74%
ROICexgc 16.65%
OM 5.94%
PM (TTM) 3.02%
GM 31.19%
FCFM 2.75%
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
ROICexc(3y)8.17%
ROICexc(5y)8.74%
ROICexgc(3y)19.66%
ROICexgc(5y)20.9%
ROCE(3y)10.93%
ROCE(5y)11.41%
ROICexgc growth 3Y-9.94%
ROICexgc growth 5Y-7.93%
ROICexc growth 3Y-12.98%
ROICexc growth 5Y-8.63%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
F-Score5
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 8.7
Debt/EBITDA 2.85
Cap/Depr 58.69%
Cap/Sales 1.38%
Interest Coverage 5.16
Cash Conversion 49.81%
Profit Quality 91.05%
Current Ratio 1.4
Quick Ratio 0.79
Altman-Z 2.69
F-Score5
WACC8%
ROIC/WACC0.83
Cap/Depr(3y)61.22%
Cap/Depr(5y)49.53%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.97%
Profit Quality(3y)112.93%
Profit Quality(5y)114.98%
High Growth Momentum
Growth
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
EPS Next Y5.82%
EPS Next 2Y6.79%
EPS Next 3Y7.97%
EPS Next 5Y7.78%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
Revenue Next Year2.46%
Revenue Next 2Y2.93%
Revenue Next 3Y3.21%
Revenue Next 5Y3.31%
EBIT growth 1Y26.48%
EBIT growth 3Y-5.01%
EBIT growth 5Y0.11%
EBIT Next Year15.59%
EBIT Next 3Y8.39%
EBIT Next 5Y7.01%
FCF growth 1Y-45.15%
FCF growth 3Y1.58%
FCF growth 5Y1.99%
OCF growth 1Y-31.93%
OCF growth 3Y6.12%
OCF growth 5Y4.66%

HENRY SCHEIN INC / HSIC FAQ

What is the ChartMill fundamental rating of HENRY SCHEIN INC (HSIC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to HSIC.


What is the valuation status of HENRY SCHEIN INC (HSIC) stock?

ChartMill assigns a valuation rating of 5 / 10 to HENRY SCHEIN INC (HSIC). This can be considered as Fairly Valued.


Can you provide the profitability details for HENRY SCHEIN INC?

HENRY SCHEIN INC (HSIC) has a profitability rating of 6 / 10.


What are the PE and PB ratios of HENRY SCHEIN INC (HSIC) stock?

The Price/Earnings (PE) ratio for HENRY SCHEIN INC (HSIC) is 17.29 and the Price/Book (PB) ratio is 2.92.


What is the earnings growth outlook for HENRY SCHEIN INC?

The Earnings per Share (EPS) of HENRY SCHEIN INC (HSIC) is expected to grow by 5.82% in the next year.